Episodes 1-15 of 712
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
On the Frontlines of SchizophreniaNegative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
NeuroFrontiersAdvancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
NeuroFrontiersUnderstanding Schizophrenia: The Role of Neurotransmission and Inflammation
Harnessing AI to Predict and Prevent Schizophrenia Relapse
NeuroFrontiersHarnessing AI to Predict and Prevent Schizophrenia Relapse
Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
NeuroFrontiersEngaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
NeuroFrontiersApplying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
- advertisement
Aducanumab in Early Alzheimer's: Slowing Cognitive and Functional Decline
NeuroFrontiersAducanumab in Early Alzheimer's: Slowing Cognitive and Functional Decline
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living RheumAdverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Evaluating Digital CBT for Sickle Cell Disease: Insights From the CaRISMA Trial
Project Oncology®Evaluating Digital CBT for Sickle Cell Disease: Insights From the CaRISMA Trial
Understanding and Treating Trauma in Pediatric Patients: Key Management Strategies
Clinician's RoundtableUnderstanding and Treating Trauma in Pediatric Patients: Key Management Strategies
Sustained Antidepressant and Sleep Benefits With Adjunctive Seltorexant in MDD: Double-Blind and Long-Term Extension Data From the MD3001 Trial
Psychiatry and Mental HealthSustained Antidepressant and Sleep Benefits With Adjunctive Seltorexant in MDD: Double-Blind and Long-Term Extension Data From the MD3001 Trial
Seltorexant vs Quetiapine XR in MDD With Insomnia: A 26-Week Phase 3 Comparison
Psychiatry and Mental HealthSeltorexant vs Quetiapine XR in MDD With Insomnia: A 26-Week Phase 3 Comparison
- advertisement
Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study
Psychiatry and Mental HealthValbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study
Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4
Psychiatry and Mental HealthValbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4
Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Project Oncology®Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
